Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: August 11, 2022

Investigational Drug Information for Gliolan

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the development status for investigational drug Gliolan?

Gliolan is an investigational drug.

There have been 16 clinical trials for Gliolan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1^st 2010.

The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are photonamic GmbH & Co. KG, National Cancer Institute (NCI), and Constantinos Hadjipanayis.

Summary for Gliolan

US Patents	0
International Patents	0
US Patent Applications	438
WIPO Patent Applications	0
Japanese Patent Applications	5,276
Clinical Trial Progress	Phase 3 (2010-11-01)
Vendors	107

Recent Clinical Trials for Gliolan

Title	Sponsor	Phase
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma	Hemerion Therapeutics	Phase 2
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma	Institut National de la Santé Et de la Recherche Médicale, France	Phase 2
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma	University Hospital, Lille	Phase 2

See all Gliolan clinical trials

Clinical Trial Summary for Gliolan

Top disease conditions for Gliolan

Top clinical trial sponsors for Gliolan

See all Gliolan clinical trials

US Patents for Gliolan

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Harvard Business School

Colorcon

Merck

Boehringer Ingelheim

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.